Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 2
2005 1
2006 1
2007 1
2008 1
2010 1
2011 5
2012 2
2013 3
2015 5
2016 5
2017 4
2018 3
2019 2
2020 3
2021 3
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.
Ongoren S, Eskazan AE, Suzan V, Savci S, Erdogan Ozunal I, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Erbilgin Y, Iseri SA, Ar MC, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T. Ongoren S, et al. Hematology. 2018 May;23(4):212-220. doi: 10.1080/10245332.2017.1385193. Epub 2017 Oct 9. Hematology. 2018. PMID: 28990873 Review.
Copy-number variations in adult patients with chronic immune thrombocytopenia.
Yucesan E, Hatirnaz Ng O, Yalniz FF, Yilmaz H, Salihoglu A, Sudutan T, Eskazan AE, Ongoren S, Baslar Z, Soysal T, Ozbek U, Sayitoglu M, Ar MC. Yucesan E, et al. Among authors: ongoren s. Expert Rev Hematol. 2020 Nov;13(11):1277-1287. doi: 10.1080/17474086.2020.1819786. Epub 2020 Sep 23. Expert Rev Hematol. 2020. PMID: 32885695
Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic.
Küçükyurt S, Şahin K, Yılmaz U, Erçalışkan A, Özkan Tekin T, Ortaboz D, Elverdi T, Salihoğlu A, Ar MC, Öngören Ş, Başlar Z, Eşkazan AE. Küçükyurt S, et al. Among authors: ongoren s. Curr Probl Cancer. 2022 Dec;46(6):100913. doi: 10.1016/j.currproblcancer.2022.100913. Epub 2022 Oct 12. Curr Probl Cancer. 2022. PMID: 36399974 Free PMC article.
Cytogenetic profile of adult AML patients in Turkey: a single center study with comprehensive comparison with literature.
Cirakoglu A, Kuru RD, Yilmaz S, Deviren A, Ongoren S, Yalniz FF, Keskin D, Eskazan AE, Salihoglu A, Cem Ar M, Sahin S, Aydin Y, Hacihanefioglu S, Baslar Z, Soysal T, Arguden YT. Cirakoglu A, et al. Among authors: ongoren s. Afr Health Sci. 2022 Sep;22(3):183-191. doi: 10.4314/ahs.v22i3.21. Afr Health Sci. 2022. PMID: 36910358 Free PMC article.
Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.
Erbilgin Y, Eskazan AE, Hatirnaz Ng O, Salihoglu A, Elverdi T, Firtina S, Tasar O, Mercan S, Sisko S, Khodzhaev K, Ongoren S, Ar MC, Baslar Z, Soysal T, Sayitoglu M, Ozbek U. Erbilgin Y, et al. Among authors: ongoren s. Leuk Lymphoma. 2019 Jan;60(1):200-207. doi: 10.1080/10428194.2018.1473573. Epub 2018 Jul 2. Leuk Lymphoma. 2019. PMID: 29965782
47 results